关注
Raphael Aparecido Boschero
Raphael Aparecido Boschero
Researcher | Biochemical Engineer | PhD in Bioprocess Engineering and Biotechnology
在 ourofino.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Cultivated meat: Recent technological developments, current market and future challenges
LAJ Letti, SG Karp, CFM Molento, BSO Colonia, RA Boschero, VT Soccol, ...
Biotechnology Research and Innovation Journal 5 (1), 0-0, 2021
102021
Alternative pharmaceutical formulation for oral administration of rifampicin
PCB Halicki, G Hädrich, R Boschero, LA Ferreira, A von Groll, ...
ASSAY and Drug Development Technologies 16 (8), 456-461, 2018
92018
Tuberculosis Treatment Facilitated by Lipid Nanocarriers: Can Inhalation Improve the Regimen?
G Hädrich, RA Boschero, AS Appel, M Falkembach, M Monteiro, ...
ASSAY and Drug Development Technologies 18 (7), 298-307, 2020
52020
Development of lipid nanocarriers for tuberculosis treatment: Evaluation of suitable excipients and nanocarriers
G Hädrich, GR Vaz, R Boschero, AS Appel, C Ramos, PCB Halicki, ...
Current Drug Delivery 18 (6), 770-778, 2021
42021
Produção de lipase microbiana a partir de resíduos de corvina
GPS Aguiar, VG Martins, PCC Martins, RA Boschero, ...
Revista de Engenharia e Tecnologia 10 (1), áginas 118-129, 2018
42018
A review on COVID-19 diagnosis tests approved for use in Brazil and the impact on pandemic control
JMD Vedova-Costa, ELP Ramos, RA Boschero, GN Ferreira, VT Soccol, ...
Brazilian Archives of Biology and Technology 64, 2021
32021
High-performance immune diagnosis of tuberculosis: Use of phage display and synthetic peptide in an optimized experimental design
NN Serena, RA Boschero, M Hospinal-Santiani, VD Pacce, JMDV Costa, ...
Journal of Immunological Methods 503, 113242, 2022
22022
ANTÍGENOS PEPTÍDEOS SINTÉTICOS PARA O DIAGNÓSTICO DO SARS-COV-2
V THOMAZ-SOCCOL, MH SANTIANI, CR SOCCOL, RA BOSCHERO, ...
BR Patent BR10,202,002,440, 0
2*
无主题
BR Patent App. 102,020,019,899 A, 2021
2021
New age in vaccinology: the impact of the COVID-19 pandemic on third-generation vaccine development
ELP Ramos, JMD Vedova-Costa, VD Pacce, GN Ferreira, YCM Guzmán, ...
Biotechnology Research and Innovation Journal 5 (1), 0-0, 2021
2021
Formulation and Validation of Recombinant Antigens CFP10 and ESAT6 for Tuberculosis Diagnosis
LDCT Araujo, DE Rodriguez-Fernández, SG Karp, ES Marquez, ...
Brazilian Archives of Biology and Technology 64, 2021
2021
Produção de biossurfactantes a partir de diferentes resíduos agroindustriais
CPH Gean Pablo Silva Aguiar, Vilásia Guimarães Martins, Paola Chaves Martins ...
Brazilian Journal of Food Research 9 (2), 2018
2018
USO DE PEPTÍDEO SINTÉTICO P.SC2.S118 PARA DIAGNÓSTICO DE COVID-19 USANDO PLATAFORMA DE IMUNODIAGNÓSTICO
V THOMAZ-SOCCOL, CR SOCCOL, ELP RAMOS, RA BOSCHERO, ...
BR Patent BR1,020,200,243,713, 0
PEPTÍDEO SINTÉTICO P.SC2.S.129 PARA IMUNODETECÇÃO DEANTICORPOS IGM, IGA E IGG CONTRA COVID-19
V THOMAZ-SOCCOL, CR SOCCOL, MH SANTIANI, RA BOSCHERO, ...
BR Patent BR1,020,200,243,802, 0
PEPTÍDEO SINTÉTICO P.SC2.S.132 PARA KIT ELISA DE AVIDEZNO DIAGNÓSTICO DE COVID-19
V THOMAZ-SOCCOL, ELP RAMOS, MH SANTIANI, RA BOSCHERO, ...
BR Patent BR1,020,200,243,900, 0
ANTÍGENO PEPTÍDEO SINTÉTICO P.SC2.S.309 APLICADO EM KIT E MÉTODO ELISA PARA DIAGNÓSTICO SOROLÓGICO DE COVID-19
V THOMAZ-SOCCOL, CR SOCCOL, RA BOSCHERO, MH SANTIANI, ...
BR Patent BR1,020,200,243,780, 0
KIT E MÉTODO ELISA PARA DIAGNÓSTICO DA TUBERCULOSEUTILIZANDO NOVO ANTÍGENO PEPTÍDEO SINTÉTICO P.Mt.PD.7
V THOMAZ-SOCCOL, NN SERENA, RA BOSCHERO, CR SOCCOL, ...
BR Patent BR10,202,001,989, 0
Influência do meio mineral na produção de Biossurfactantes
VGM FURG, PCM FURG, CPH FURG
系统目前无法执行此操作,请稍后再试。
文章 1–18